Covid-19 i vakcinacija

Abstract

Nakon prvog slučaja infekcije SARS-CoV-2 virusom u Kini krajem 2019. godine, COVID-19 brzo prerasta u epidemiju, a zatim i pandemiju. Prema najnovijim po- dacima COVID-19 pandemija beleži oko 250 miliona zaraženih ljudi u svetu i preko 5 miliona smrtnih slučajeva kao posledica COVID-19 infekcije. U radu su, na osnovu pregleda relevantne literature, prikazani podaci o vak- cinama dostupnim u našoj zemlji, njihovim karakteristikama, vakcinaciji trudnica i dece, kao i preporuke Svetske zdravstvene organizacije i Centra za kontrolu i prevenciju bolesti, za primenu vakcina. I pored dostupnosti vakcina, stepen vakcinacije u našoj zemlji još uvek nije doveo do stvaranja kolektivnog imuniteta. Razlog leži u nepoverenju prema vakcinama zbog njihovog brzog puštanja u upotrebu. To nameće potrebu za jasnim i pouzdanim preporukama zdravstvenih radnika kako bi se ublažila zabrinu- tost u vezi sa bezbednošću vakcina.

After the first case of SARS-CoV-2 virus infection in China at the end of 2019, COVID-19 quickly grew into an epidemic, and then a pandemic. According to the latest data from the COVID-19 pandemic, there are about 250 million infected and over 5 million deaths in the world as a result of the COVID-19 infection. Based on a review of relevant literature, the paper presents data on vaccines available in our country, their characteristics, vaccination of pregnant women and children, as well as the recommendations of the World Health Organization and the Center for Disease Control and Prevention for vaccines. Despite the availability of vaccines, the level of vaccination in our country has not yet led to the collective immunity. The main reason lies in the distrust of vaccines due to their rapid release. This imposes the need for clear and reliable recommendations from healthcare professionals to alleviate concerns about vaccine safety.